β-Thalassemia (β-thal) is a genetic disorder characterized by mutations on the β-globin gene (HBB) that lead either to decreased or absent β-globin chain synthesis. β-Thalassemia mutations are located throughout the gene, affecting almost every aspect of gene expression. The heterogeneous nature of β-thal is well known and more than 200 different molecular defects have been characterized (1) . This group of diseases represents the most widespread hereditary hemoglobin (Hb) disorders and has been found in practically every population examined. The worldwide distribution of HBB mutant alleles is non random; each ethnic group in which the disease is prevalent has a different spectrum of HBB gene mutations (2) (3) (4) .
Although occurrences of β-thal in Brazil have been recognized for a long time, information on prevalence of the disease in this country is scarce and fragmented. Brazil has a multi-ethnic population of almost 200 million people, with a high level of admixture of European, African, Asian and indigenous ancestries that are unevenly distributed over a continental expanse of 8.5 million km 2 (5) . Brazilians, therefore, form one of the most heterogeneous populations in the world and population composition varies widely between regions (6,7). Consequently, these facts suggest that the incidence of β-thal should be heterogeneous and that it may be difficult to determine the distribution of HBB gene mutations in this country.
The frequency of β-thal heterozygotes in South and Southeast Brazil is estimated at around 1.0% (8, 9) , with most carriers being of Italian descent. The β-thal prevalence in North and Northeast Brazil is still undetermined and the few studies from this region to report molecular aspects showed a higher prevalence of HBB: c.92þ6T>C and HBB: c.92þ1G>A. However, the HBB: c.92þ5G>C [IVS-I-5 (G>C); β nt 147 (G>C)], an Indian-Asian mutation mostly described on the Indian subcontinent, Pakistan, Sri Lanka, Mauritius Island, Oman and other part of the Middle East, has also been found (13) (14) (15) .
The present study aimed to identify the prevalence and variability of β-thal in the Brazilian state of Bahia, located in the northeastern region of the country, where about 80.0% of the population is Black or mixed, identifying the β-thal mutations, concentration of Hb, mean cell volume (MCV), mean cell Hb (MCH), Hb A 2 and Hb F values, related to the disease. This is the first study designed to analyze this kind of thalassemia in the population of Bahia State, Brazil.
The sample group consisted of 1011 male adolescents aged from 17 to 19 years, who presented at the Army Selection Center in Salvador, Bahia, Brazil in 2003, and were exempted from military service due to excess of applicants. Blood samples were drawn by venipuncture using EDTA as an anticoagulant. Hematological data were obtained using an automated cell counter (Coulter Counter T890; Beckman Coulter, Brea, CA, USA), Hb profiles were studied by the high performance liquid chromatography (HPLC) technique using the VARIANT™ II, β-Thalassemia Program (Bio-Rad Laboratories, Hercules, CA, USA). The two cases that presented with Hb A 2 levels greater than or equal to 3.5%, independently of MCV and MCH, had the most extensively researched β-thal mutations. DNA sequencing was performed using an automated DNA sequencer (ABI PRISM® 3100 Automatic Genetic Analyzer; Applied Biosystems, Foster City, CA, USA), with the BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). The DNA sequencing was repeated three times for each experiment, using different polymerase chain reaction (PCR) products in order to confirm the findings. The techniques were developed at the Laboratory of Pathology and Molecular Biology of the "Centro de Pesquisa Gonçalo Moniz" of the "Fundação Oswaldo Cruz" (CPqGM/FIOCRUZ).
One individual heterozygous for a β-thal mutation was identified (prevalence of 0.1%). Despite the sample size being relatively small, the low prevalence of β-thal heterozygotes are in agreement with the data related to the ethnic origins of the Bahian population (80.0% of African descent), and with the prevalence estimated through the absence, in the state of Bahia, of newborns homozygous for β-thal mutations identified through newborn screening (16, 17) . Table 1 shows hematological and molecular data related to both the studied individuals. The subjects were unable to give information regarding ancestry.
Significantly, in the approximately 100-year period from 1872 to 1975, Brazil received a large number of immigrants from Europe and other parts of the world (34.0% Italians, 29.0% Portuguese, 14.0% Spanish, 5.0% Japanese, 4.0% Germans, 2.0% Lebanese and Syrians, and 12.0% others) (5) .
The state of Bahia was the site at which the Portuguese first arrived in Brazil in 1500. Also, the African slave trade had Bahia as one of its main receiving points in Brazil. In the 18th century, the region was attacked by the Dutch, who were later expelled by the Portuguese. Driven out of Portugal, many Jews also settled in northeastern Brazil in the 17th century. For about a Prevalence and Characterization of β-Thalassemia century, Bahia retained the title of the most important seaport in the southern hemisphere, carrying out heavy trade with Europe, Asia and Africa. Added to this, from the years of World War I and into the 1920s and 1930s, further Jewish immigrants from Eastern and Western Europe and the Middle East formed structured communities in Salvador, Bahia (18) .
The four Mediterranean mutations most often found in previous studies in Brazil (HBB: c.118C>T; HBB: c.93-21G>A; HBB: c.92þ1G>A; HBB: c.92þ6T>C) were not detected in the current analysis. The HBB: c.135delC had never been previously reported in the Brazilian population. It has been frequently reported in Kurdish Jews, and rarely in various populations around the Mediterranean Sea and the Middle East. HBB: c.135delC homozygotes have a clinical picture of severe thalassemia, while heterozygotes show light anemia with important microcytosis and hypocromia, which were also observed in our case (19) (20) (21) (22) . Figure 1 shows the electropherograms of the subject who was heterozygous for the HBB: c.135delC [codon 44 (-C); TCC(Ser)>TC-(β 0 )]. For each electropherogram, a separate PCR was performed.
In the second individual, who showed elevated levels of Hb A 2 , we identified only the polymorphism C>T at codon 2, which has been identified in patients with β-thal alleles and also in normal individuals without thalassemia mutations (23, 24) . Sonati et al. reported an 8-year-old Brazilian girl with sickle cell-β-thal, who had the HBB: c.92þ6T>C [IVS-I-6 (T>C)] mutation associated with the C>T polymorphism at codon 2. The DNA sequencing of the patient's mother showed her to be heterozygous for the HBB: c.92þ6T>C and homozygous for the C>T polymorphism at codon 2 (25) .
The HBB: c.135delC mutation demonstrates an unusual component in the genetic makeup of the Brazilian population, supporting the high degree miscegenation. To disclose the real prevalence and the full spectrum of β-thal mutations in Brazil, it would be necessary to analyze individuals from all over the country. 
